{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:45:34Z","timestamp":1792273534429,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangdong Provincial Hospital Pharmaceutical Research Fund","award":["2024A09"],"award-info":[{"award-number":["2024A09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10735-026-10924-x","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:46:52Z","timestamp":1786373212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NAT10-mediated ac4C acetylation of PKM2 promotes papillary thyroid carcinoma through regulating glycolysis"],"prefix":"10.1007","volume":"57","author":[{"given":"Guobin","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghuan","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"10924_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.7150\/ijms.29935","volume":"16","author":"MI Abdullah","year":"2019","unstructured":"Abdullah MI, Junit SM, Ng KL, Jayapalan JJ, Karikalan B, Hashim OH (2019) Papillary thyroid cancer: genetic alterations and molecular biomarker investigations. Int J Med Sci 16:450\u2013460. https:\/\/doi.org\/10.7150\/ijms.29935","journal-title":"Int J Med Sci"},{"key":"10924_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME (2024) Thyroid Cancer. Rev JAMA 331:425\u2013435. https:\/\/doi.org\/10.1001\/jama.2023.26348","journal-title":"Rev JAMA"},{"key":"10924_CR31","doi-asserted-by":"publisher","first-page":"e1088","DOI":"10.1002\/ctm2.1088","volume":"12","author":"T Dai","year":"2022","unstructured":"Dai T, Zhang X, Zhou X, Hu X, Huang X, Xing F et al (2022) Long non-coding RNA VAL facilitates PKM2 enzymatic activity to promote glycolysis and malignancy of gastric cancer. Clin Transl Med 12:e1088. https:\/\/doi.org\/10.1002\/ctm2.1088","journal-title":"Clin Transl Med"},{"key":"10924_CR35","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.15252\/embr.201643300","volume":"17","author":"TL Dayton","year":"2016","unstructured":"Dayton TL, Jacks T, Vander HM (2016) PKM2, cancer metabolism, and the road ahead. EMBO Rep 17:1721\u20131730. https:\/\/doi.org\/10.15252\/embr.201643300","journal-title":"EMBO Rep"},{"key":"10924_CR33","doi-asserted-by":"publisher","first-page":"E1524","DOI":"10.1210\/jc.2012-4258","volume":"98","author":"C Feng","year":"2013","unstructured":"Feng C, Gao Y, Wang C, Yu X, Zhang W, Guan H et al (2013) Aberrant overexpression of pyruvate kinase M2 is associated with aggressive tumor features and the BRAF mutation in papillary thyroid cancer. J Clin Endocrinol Metab 98:E1524\u2013E1533. https:\/\/doi.org\/10.1210\/jc.2012-4258","journal-title":"J Clin Endocrinol Metab"},{"key":"10924_CR16","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.3390\/ijms231710037","volume":"23","author":"A Fukushi","year":"2022","unstructured":"Fukushi A, Kim HD, Chang YC, Kim CH (2022) Revisited metabolic control and reprogramming cancers by means of the Warburg effect in tumor cells. Int J Mol Sci 23:10037. https:\/\/doi.org\/10.3390\/ijms231710037","journal-title":"Int J Mol Sci"},{"key":"10924_CR12","doi-asserted-by":"publisher","first-page":"e7283","DOI":"10.1002\/cam4.7283","volume":"13","author":"Q Guo","year":"2024","unstructured":"Guo Q, Yu W, Tan J, Zhang J, Chen J, Rao S et al (2024) Remodelin delays non-small cell lung cancer progression by inhibiting NAT10 via the EMT pathway. Cancer Med 13:e7283. https:\/\/doi.org\/10.1002\/cam4.7283","journal-title":"Cancer Med"},{"key":"10924_CR34","doi-asserted-by":"publisher","first-page":"e33232","DOI":"10.1097\/MD.0000000000033232","volume":"102","author":"Z Hao","year":"2023","unstructured":"Hao Z, Wang Y, Li J, Liu W, Zhao W, Wang J (2023) Expression of HIF-1alpha\/PKM2 axis correlates to biological and clinical significance in papillary thyroid carcinoma. Med (Baltim) 102:e33232. https:\/\/doi.org\/10.1097\/MD.0000000000033232","journal-title":"Med (Baltim)"},{"key":"10924_CR5","doi-asserted-by":"publisher","first-page":"748941","DOI":"10.3389\/fendo.2021.748941","volume":"12","author":"DA Hescheler","year":"2021","unstructured":"Hescheler DA, Riemann B, Hartmann M, Michel M, Faust M, Bruns CJ et al (2021) Targeted therapy of papillary thyroid cancer: a comprehensive genomic analysis. Front Endocrinol (Lausanne) 12:748941. https:\/\/doi.org\/10.3389\/fendo.2021.748941","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10924_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13046-022-02254-z","volume":"41","author":"J Huang","year":"2022","unstructured":"Huang J, Sun W, Wang Z, Lv C, Zhang T, Zhang D et al (2022) FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner. J Exp Clin Cancer Res 41:42. https:\/\/doi.org\/10.1186\/s13046-022-02254-z","journal-title":"J Exp Clin Cancer Res"},{"key":"10924_CR25","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/cas.15772","volume":"114","author":"X Ji","year":"2023","unstructured":"Ji X, Lv C, Huang J, Dong W, Sun W, Zhang H (2023) ALKBH5-induced circular RNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2. Cancer Sci 114:2318\u20132334. https:\/\/doi.org\/10.1111\/cas.15772","journal-title":"Cancer Sci"},{"key":"10924_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.omtn.2020.01.037","volume":"20","author":"G Jin","year":"2020","unstructured":"Jin G, Xu M, Zou M, Duan S (2020) The processing, gene regulation, biological functions, and clinical relevance of N4-acetylcytidine on RNA: a systematic review. Mol Ther Nucleic Acids 20:13\u201324. https:\/\/doi.org\/10.1016\/j.omtn.2020.01.037","journal-title":"Mol Ther Nucleic Acids"},{"key":"10924_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13046-022-02551-7","volume":"41","author":"C Jin","year":"2022","unstructured":"Jin C, Wang T, Zhang D, Yang P, Zhang C, Peng W et al (2022) Acetyltransferase NAT10 regulates the Wnt\/beta-catenin signaling pathway to promote colorectal cancer progression via ac(4)C acetylation of KIF23 mRNA. J Exp Clin Cancer Res 41:345. https:\/\/doi.org\/10.1186\/s13046-022-02551-7","journal-title":"J Exp Clin Cancer Res"},{"key":"10924_CR15","doi-asserted-by":"publisher","first-page":"188988","DOI":"10.1016\/j.bbcan.2023.188988","volume":"1878","author":"H Kang","year":"2023","unstructured":"Kang H, Kim B, Park J, Youn H, Youn B (2023) The Warburg effect on radioresistance: survival beyond growth. Biochim Biophys Acta Rev Cancer 1878:188988. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188988","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10924_CR4","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s00423-021-02189-7","volume":"406","author":"SJ Lee","year":"2021","unstructured":"Lee SJ, Song CM, Ji YB, Choi YY, Sohn YS, Park JH et al (2021) Risk factors for hypothyroidism and thyroid hormone replacement after hemithyroidectomy in papillary thyroid carcinoma. Langenbecks Arch Surg 406:1223\u20131231. https:\/\/doi.org\/10.1007\/s00423-021-02189-7","journal-title":"Langenbecks Arch Surg"},{"key":"10924_CR11","doi-asserted-by":"publisher","first-page":"8514","DOI":"10.1093\/nar\/gkad628","volume":"51","author":"R Liu","year":"2023","unstructured":"Liu R, Wubulikasimu Z, Cai R, Meng F, Cui Q, Zhou Y et al (2023) NAT10-mediated N4-acetylcytidine mRNA modification regulates self-renewal in human embryonic stem cells. Nucleic Acids Res 51:8514\u20138531. https:\/\/doi.org\/10.1093\/nar\/gkad628","journal-title":"Nucleic Acids Res"},{"key":"10924_CR22","doi-asserted-by":"publisher","first-page":"936","DOI":"10.24976\/Discov.Med.202335179.89","volume":"35","author":"X Liu","year":"2023","unstructured":"Liu X, Liu X, Zhuo C, Shen J, Lu K, Sha M et al (2023) NAT10 promotes malignant progression of lung cancer via the NF-kappaB signaling pathway. Discov Med 35:936\u2013945. https:\/\/doi.org\/10.24976\/Discov.Med.202335179.89","journal-title":"Discov Med"},{"key":"10924_CR24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-4062","author":"S Liu","year":"2024","unstructured":"Liu S, Lin C, Lin X, Lin P, He R, Pan X et al (2024) NAT10 Phase separation regulates YTHDF1 splicing to promote gastric cancer progression. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-4062","journal-title":"Cancer Res"},{"key":"10924_CR23","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.7150\/ijms.83828","volume":"20","author":"Y Long","year":"2023","unstructured":"Long Y, Ren Y, Wei Q, Mobet Y, Liu Y, Zhao H et al (2023) NAT10-mediated RNA acetylation enhances HNRNPUL1 mRNA stability to contribute cervical cancer progression. Int J Med Sci 20:1079\u20131090. https:\/\/doi.org\/10.7150\/ijms.83828","journal-title":"Int J Med Sci"},{"key":"10924_CR7","doi-asserted-by":"publisher","first-page":"1267755","DOI":"10.3389\/fimmu.2023.1267755","volume":"14","author":"LL Lou","year":"2023","unstructured":"Lou LL, Qiu WR, Liu Z, Xu ZC, Xiao X, Huang SF (2023) Stacking-ac4C: an ensemble model using mixed features for identifying n4-acetylcytidine in mRNA. Front Immunol 14:1267755. https:\/\/doi.org\/10.3389\/fimmu.2023.1267755","journal-title":"Front Immunol"},{"key":"10924_CR19","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1002\/sim.5777","volume":"32","author":"H Ma","year":"2013","unstructured":"Ma H, Bandos AI, Rockette HE, Gur D (2013) On use of partial area under the ROC curve for evaluation of diagnostic performance. Stat Med 32:3449\u20133458. https:\/\/doi.org\/10.1002\/sim.5777","journal-title":"Stat Med"},{"key":"10924_CR21","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.3390\/ijms23126573","volume":"23","author":"N Ma","year":"2022","unstructured":"Ma N, Liu H, Wu Y, Yao M, Zhang B (2022) Inhibition of N-acetyltransferase 10 suppresses the progression of prostate cancer through regulation of DNA replication. Int J Mol Sci 23:6573. https:\/\/doi.org\/10.3390\/ijms23126573","journal-title":"Int J Mol Sci"},{"key":"10924_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/PAP.0000000000000184","volume":"25","author":"MC Nath","year":"2018","unstructured":"Nath MC, Erickson LA (2018) Aggressive variants of papillary thyroid carcinoma: hobnail, tall cell, columnar, and solid. Adv Anat Pathol 25:172\u2013179. https:\/\/doi.org\/10.1097\/PAP.0000000000000184","journal-title":"Adv Anat Pathol"},{"key":"10924_CR14","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.semcancer.2022.09.007","volume":"86","author":"S Paul","year":"2022","unstructured":"Paul S, Ghosh S, Kumar S (2022) Tumor glycolysis, an essential sweet tooth of tumor cells. Semin Cancer Biol 86:1216\u20131230. https:\/\/doi.org\/10.1016\/j.semcancer.2022.09.007","journal-title":"Semin Cancer Biol"},{"key":"10924_CR2","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.2217\/fon.10.127","volume":"6","author":"R Rahbari","year":"2010","unstructured":"Rahbari R, Zhang L, Kebebew E (2010) Thyroid cancer gender disparity. Future Oncol 6:1771\u20131779. https:\/\/doi.org\/10.2217\/fon.10.127","journal-title":"Future Oncol"},{"key":"10924_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s12885-024-12199-5","volume":"24","author":"J Shen","year":"2024","unstructured":"Shen J, Ma Z, Yang J, Qu T, Xia Y, Xu Y et al (2024) CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p\/PKM2 axis. BMC Cancer 24:511. https:\/\/doi.org\/10.1186\/s12885-024-12199-5","journal-title":"BMC Cancer"},{"key":"10924_CR27","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","volume":"95","author":"P Vaupel","year":"2019","unstructured":"Vaupel P, Schmidberger H, Mayer A (2019) The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol 95:912\u2013919. https:\/\/doi.org\/10.1080\/09553002.2019.1589653","journal-title":"Int J Radiat Biol"},{"key":"10924_CR28","doi-asserted-by":"publisher","first-page":"19019","DOI":"10.1002\/jcp.28541","volume":"234","author":"K Wang","year":"2019","unstructured":"Wang K, Chai L, Qiu Z, Zhang Y, Gao H, Zhang X (2019) Overexpression of TRIM26 suppresses the proliferation, metastasis, and glycolysis in papillary thyroid carcinoma cells. J Cell Physiol 234:19019\u201319027. https:\/\/doi.org\/10.1002\/jcp.28541","journal-title":"J Cell Physiol"},{"key":"10924_CR29","doi-asserted-by":"publisher","first-page":"e738","DOI":"10.1002\/ctm2.738","volume":"12","author":"G Wang","year":"2022","unstructured":"Wang G, Zhang M, Zhang Y, Xie Y, Zou J, Zhong J et al (2022) NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Clin Transl Med 12:e738. https:\/\/doi.org\/10.1002\/ctm2.738","journal-title":"Clin Transl Med"},{"key":"10924_CR10","doi-asserted-by":"publisher","first-page":"112810","DOI":"10.1016\/j.celrep.2023.112810","volume":"42","author":"W Wei","year":"2023","unstructured":"Wei W, Zhang S, Han H, Wang X, Zheng S, Wang Z et al (2023) NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer. Cell Rep 42:112810. https:\/\/doi.org\/10.1016\/j.celrep.2023.112810","journal-title":"Cell Rep"},{"key":"10924_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.omtn.2023.03.023","volume":"32","author":"L Xie","year":"2023","unstructured":"Xie L, Zhong X, Cao W, Liu J, Zu X, Chen L (2023) Mechanisms of NAT10 as ac4C writer in diseases. Mol Ther Nucleic Acids 32:359\u2013368. https:\/\/doi.org\/10.1016\/j.omtn.2023.03.023","journal-title":"Mol Ther Nucleic Acids"},{"key":"10924_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13578-023-00987-8","volume":"13","author":"D Xu","year":"2023","unstructured":"Xu D, Yu J, Yang Y, Du Y, Lu H, Zhang S et al (2023) RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1\/HDAC6 complex. Cell Biosci 13:36. https:\/\/doi.org\/10.1186\/s13578-023-00987-8","journal-title":"Cell Biosci"},{"key":"10924_CR13","doi-asserted-by":"publisher","first-page":"116688","DOI":"10.1016\/j.taap.2023.116688","volume":"477","author":"Z Yang","year":"2023","unstructured":"Yang Z, Wilkinson E, Cui Y, Li H, He Y (2023) NAT10 regulates the repair of UVB-induced DNA damage and tumorigenicity. Toxicol Appl Pharmacol 477:116688. https:\/\/doi.org\/10.1016\/j.taap.2023.116688","journal-title":"Toxicol Appl Pharmacol"},{"key":"10924_CR30","first-page":"1793","volume":"10","author":"G Yu","year":"2018","unstructured":"Yu G, Sun W, Shen Y, Hu Y, Liu H, Li W et al (2018) PKM2 functions as a potential oncogene and is a crucial target of miR-148a and miR-326 in thyroid tumorigenesis. Am J Transl Res 10:1793\u20131801","journal-title":"Am J Transl Res"},{"key":"10924_CR18","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/s42003-022-03868-x","volume":"5","author":"H Zhang","year":"2022","unstructured":"Zhang H, Chen Z, Zhou J, Gu J, Wu H, Jiang Y et al (2022) NAT10 regulates neutrophil pyroptosis in sepsis via acetylating ULK1 RNA and activating STING pathway. Commun Biol 5:916. https:\/\/doi.org\/10.1038\/s42003-022-03868-x","journal-title":"Commun Biol"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10924-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10924-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10924-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:19:38Z","timestamp":1792271978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10924-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10924"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10924-x","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical study was approved by the Ethics Committee of Shenzhen Hospital of Southern Medical University (No.2025-0004). This study was performed in line with the principles of the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study. The animal study was approved by the Ethics Committee of Shenzhen Hospital of Southern Medical University. All animal experiments complied with the ARRIVE guidelines. All methods were carried out in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"265"}}